CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.

Parts shortages are turning young aircraft into donor planes, upending fleet economics for airlines and lessors.

The long-awaited sequel to a modern classic is being pulled from screens after a brutal critical and commercial reception. Here's what it signals for studios betting on nostalgia.

Kashim Chowdhury denies dishonesty after concealing multiple public-sector roles. The case puts remote-work ethics and criminal liability in the spotlight.

The Chinese startup's latest model threatens to upend AI economics and the valuations built on them.

The YouTube-native studio is expanding beyond platform revenue with a four-acre LA campus and partnerships with Disney and Fox. Here's what it means for media executives.

A portable, electricity-free diagnostic could transform emergency care in ambulances, disaster zones, and remote clinics where lab machines are out of reach.

The EV maker's new FF Nova targets developers and schools, but the bigger story is FFR's all-stock purchase of its robotics business.

Market cap, Musk wealth, and retail mechanics collide with acquisition-driven AI spend and looming investor scrutiny.

Lovable, Replit, and others are raising billions as Big Tech both bets on and panics about AI-built software.

The IPO lands on Nasdaq as critics question Musk’s near-absolute ownership, and the filings force boards to look hard.

SpaceX wants to raise up to $75bn at $135 a share, but critics say the fixed-price deal may leave buyers overpaying before book building even starts.